Safety data from multiple bendamustine trials involving patients with indolent NHL or CLL are summarized in Table 3. [4,6,21–23,26,42] Preliminary data from a comparative clinical trial ...

The rate of non-Hodgkin's lymphoma has nearly doubled since the 1970s, but advances in treatments are offering new hope. Laura Colton Tepper had just endured her second round of chemotherapy for ...

a rare form of non-Hodgkin lymphoma (NHL). The recommended zanubrutinib dosage for CLL/SLL is 160 mg taken orally twice daily or 320 mg taken orally once daily until disease progression or ...

Blood tests, bone marrow tests, imaging tests, and biopsy are some of the tests used to help diagnose chronic lymphocytic leukemia (CLL). Chronic lymphocytic leukemia (CLL) is a slow-growing ...

“We are rapidly advancing multiple clinical trials of ICP-248 globally, including the treatment of non-Hodgkin's lymphoma ...

Non-Hodgkin lymphoma (NHL) is a type of blood cancer that affects white blood cells called lymphocytes. It is also called a cancer of the lymphatic system. This is because it starts in lymph nodes or ...